Weight trajectories throughout adulthood and prostate cancer incidence, aggressiveness, and death in 258 494 men

Read full text
Authors: Marisa da Silva, Josef Fritz, Ahmed Elhakeem, Sylvia H. J. Jochems, Ming Sun, Innocent B. Mboya, Christel Häggström, Jens Wahlström, Karl Michaëlsson, Patrik K. E. Magnusson, Ylva Trolle Lagerros, Lena Lönnberg
+10 more Abbas Chabok, Sölve Elmståhl, Bright I. Nwaru, Hannu Kankaanranta, Linnéa Hedman, Helena Bäckman, Sara Hägg, Pär E. Stattin, Kate M. Tilling, Tanja Stocks
Cited by: 0

Abstract

BACKGROUND: Obesity assessed at a single time point in adulthood has shown no consistent association with prostate cancer (PCa) incidence but has been positively associated with PCa death. We investigated the association of total and age-specific adult weight trajectories with PCa aggressiveness and death. METHODS: We analyzed data from 258,494 men in Sweden with at least 3 weight observations between ages 17 and 60. Individual weight trajectories were estimated using linear mixed-effects models with natural cubic and linear splines for age, incorporating random intercepts and slopes. These estimates were included in multivariable-adjusted Cox proportional hazards models. RESULTS: Over a median follow-up of 25 years, 22 055 men were diagnosed with PCa and 4547 died from the disease. Steep weight gain was inversely associated with PCa diagnosed during the PSA testing era (1997 onwards) and via asymptomatic PSA testing, but not with aggressive PCa. Among men with PCa, steep weight gain was associated with increased risk of PCa death (HR quintile 5 vs. 1 = 1.23, 95% CI = 1.08 to 1.40), primarily driven by weight gain between ages 45 and 60 (HR per 1 kg/year = 1.31, 95% CI = 1.10 to 1.57). CONCLUSIONS: The associations observed for incident PCa appear to be influenced by PSA testing uptake; however, the extent to which detection bias contributes remains uncertain. Conversely, late midlife weight gain was associated with an elevated risk of PCa death, underscoring the importance of weight management during this period as a potentially modifiable factor for reducing PCa death.

Fields of Study & Subjects

Cancer Risks and Factors Prostate Cancer Diagnosis and Treatment Prostate Cancer Treatment and Research

Publication details

Journal / source
JNCI Journal of the National Cancer Institute
Volume
118
Issue
6
Pages
1006–1014
Publication date
19 January 2026
Language
EN